The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
Open accessAbstract
Paradoxical reactions are immune-mediated exacerbations of disease triggered by tuberculosis treatment. Paradoxical reactions involving the central nervous system may be life threatening. Infliximab (tumor necrosis factor antibody) profoundly inhibits cellular immune responses to Mycobacterium tuberculosis. We describe a case in which infliximab was used to control steroid-resistant tuberculosis paradoxical reaction involving the central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Afghani, B., & Lieberman, J. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.6.1092 · Cited by 270 · cited 2×
“The manifestations of TB often continue to evolve during the early period of treatment in patients with extrapulmonary disease, including the appearance and progression of tuberculomas in patients who present initially with meningitis [2].”
BackgroundReconsidering Adjuvant Immunotherapy for Tuberculosis
Wallis, R. S. (2005) · Clinical Infectious Diseases · doi:10.1086/430914 · Cited by 121
Self-citation
Cited by
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Thwaites, G., Fisher, M., Hemingway, C., Scott, G., Solomon, T., & Innes, J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.06.011 · Cited by 666
The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
Tobin, D. M., Vary, J. C., Ray, J. P., Walsh, G. S., Dunstan, S. J., Bang, N. D., Hagge, D. A., Khadge, S., King, M.-C., Hawn, T. R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.013 · Cited by 528
Sharma, S. K., Mohan, A., & Kohli, M. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1927718 · Cited by 441
Advancing host-directed therapy for tuberculosis
Wallis, R. S., & Hafner, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3813 · Cited by 291
Self-citationTumour necrosis factor antagonists: structure, function, and tuberculosis risks
Wallis, R. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70227-5 · Cited by 275
Self-citationParadoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis
Cho, O.-H., Park, K.-H., Kim, T., Song, E. H., Jang, E.-Y., Lee, E. J., Chong, Y. P., Choi, S.-H., Lee, S.-O., Woo, J. H., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.05.006 · Cited by 87
Tuberculosis of the lymph nodes: Many facets, many hues
Mahashur, A., & Gandhare, A. (2017) · Astrocyte · doi:10.4103/astrocyte.astrocyte_65_17 · Cited by 25
Metadata
- Authors
- Blackmore, T. K., Manning, L., Taylor, W. J., & Wallis, R. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11-15
- Volume
- 47
- Issue
- 10
- Pages
- e83-e85
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2127119945
- Cited by
- 179
- References
- 2
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.